Neurociencias
Departamento
T.
Castillo Triviño
Publicaciones en las que colabora con T. Castillo Triviño (17)
2023
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
2022
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
2021
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)
Revista de neurologia, Vol. 72, Núm. 11, pp. 397-406
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II)
Revista de neurologia, Vol. 72, Núm. 12, pp. 433-442
2020
2016
-
DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease
Movement Disorders, Vol. 31, Núm. 3, pp. 335-343
-
SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent
Scientific Reports, Vol. 6
2015
-
Age gene expression and coexpression progressive signatures in peripheral blood leukocytes
Experimental Gerontology, Vol. 72, pp. 50-56
-
Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis
BMC Genomics, Vol. 16, Núm. 1
-
Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry
2014
-
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients
Multiple Sclerosis Journal, Vol. 20, Núm. 14, pp. 1851-1859
-
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis
Biomarkers in Medicine, Vol. 8, Núm. 5, pp. 653-661
-
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression
PLoS ONE, Vol. 9, Núm. 2
2013
-
Clinical response to thalidomide in the treatment of intracranial tuberculomas: Case report
Clinical Neuropharmacology, Vol. 36, Núm. 2, pp. 70-72
2012
-
HLA-DRB1*15:01 and multiple sclerosis: A female association?
Multiple Sclerosis Journal, Vol. 18, Núm. 5, pp. 569-577
-
Hepatitis autoinmune en un paciente con esclerosis múltiple en tratamiento con acetato de glatiramero.
Revista de neurologia
2009
-
Differential micro RNA expression in PBMC from multiple sclerosis patients
PLoS ONE, Vol. 4, Núm. 7